Terminally Ill Access to Treatment Act of 1998
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (May 21, 1998)
Terminally Ill Access to Treatment Act of 1998 - Directs the Secretary of Health and Human Services to approve for treating the terminally ill drugs and devices that have not received Food and Drug Administration (FDA) final approval and have not been shown to be unsafe. Declares that it is not illegal for a health care practitioner to administer a drug or device approved under this Act if the practitioner has notified the patient that the drug or device is experimental and not FDA-approved, and has received written approval from the patient or the patient's representative.
Requires: (1) a practitioner to stop treatment and report to the Secretary if a drug or device causes acute harm; and (2) the Secretary to give public notice of an approved drug's or device's benefits or harm.
What just happenedJun 5, 1998
Referred to the Subcommittee on Health and Environment.
Who’s behind it
- Introduced in HouseMay 21, 1998
- Jun 5, 1998CommitteeH11000
Referred to the Subcommittee on Health and Environment.
Health and Environment Subcommittee - May 21, 1998IntroReferralH11100
Referred to the House Committee on Commerce.
Energy and Commerce Committee - May 21, 1998IntroReferralIntro-H
Introduced in House
- May 21, 1998IntroReferral1000
Introduced in House